JPMorgan's S&P 8,000 crystal ball has Wall Street practically drooling, but everyone's missing the real story unfolding right under their noses — earnings quality is quietly going to hell. Take UnitedHealth's latest "beat." Sure, they crushed estimates, but dig deeper and you'll find they're sitting on a staggering $16.1B in cash and short-term investments while their .

Research these companies